Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2024
A Systematic Literature Review of Psychological Interventions for Adults with Type 1 DiabetesOnyinye Diribe, Karen Palmer, Adee Kennedy, et al.
Plos One|June 10, 2011
Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndromeCecile Dessapt-Baradez, Maria Reza, Ghayathri Sivakumar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 8, 2009
Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulationCecile Dessapt, Marc Olivier Baradez, Anthea Hayward, et al.
Diabetes Care|January 14, 2010
Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuriaCecile Dessapt, Janaka Karalliedde, Maria Hernandez-Fuentes, et al.
American Journal of Nephrology|September 4, 2010
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetesGiorgia Setti, Anthea Hayward, Cecile Dessapt, et al.
Kidney International|March 1, 2013
Albuminuria is associated with too few glomeruli and too much testosteroneDavid A Long, Maria Kolatsi-Joannou, Karen L Price, et al.
Advances in Therapy|May 12, 2021
One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)Juliana C N Chan, Juan José Gagliardino, Hasan Ilkova, et al.
Diabetes, Obesity & Metabolism|May 25, 2019
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trialMelanie J Davies, David Russell-Jones, Thomas M Barber, et al.
Hypertension (Dallas, Tex. : 1979)|November 15, 2012
A role for TRPV1 in influencing the onset of cardiovascular disease in obesityNichola J Marshall, Lihuan Liang, Jennifer Bodkin, et al.
Hypertension (Dallas, Tex. : 1979)|February 12, 2014
An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stressSarah-Jane Smillie, Ross King, Xenia Kodji, et al.
Pageof 2